drugset / Trial / NCT00073814

Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

NCT00073814

Phase 3 Completed 80 enrolled Sumitomo Pharma America, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Study of Daily Dosing with Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects with Asthma

Timeline

Start
2002-12
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levalbuterol Other / unclassified 90 ug Inhaled
Comparator racemic albuterol Unknown 180 ug Inhaled

Indications